Trial Profile
Study investigating efficacy of entecavir combined with Hepatitis B Immune globulin as prophylaxis for HBV recurrence in patients undergoing HBV-related liver transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Dec 2015
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Hepatitis B immune globulin
- Indications Hepatitis B
- Focus Therapeutic Use
- 29 Dec 2015 New trial record